These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37308885)

  • 41. National Treatment Patterns and Outcomes for Hospitalized Patients with Chronic Limb-Threatening Ischemia and End-Stage Kidney Disease.
    Shah SK; Neal D; Berceli SA; Segal M; Cooper MA; Huber TS; Upchurch GR; Scali ST
    Vasc Endovascular Surg; 2023 May; 57(4):357-364. PubMed ID: 36541126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aorto-iliac and infrainguinal artery occlusive disease: different revascularization options according to the critical limb threatening ischemia category.
    Pini R; Faggioli G; Angherà C; Cappiello A; Abualhin M; Pomatto S; Gallitto E; Gargiulo M
    Int Angiol; 2023 Jun; 42(3):209-215. PubMed ID: 37067388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients with depression are less likely to go home after critical limb revascularization.
    Ramirez JL; Zahner GJ; Arya S; Grenon SM; Gasper WJ; Sosa JA; Conte MS; Iannuzzi JC
    J Vasc Surg; 2021 Jul; 74(1):178-186.e2. PubMed ID: 33383108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative anemia associated with adverse outcomes after infrainguinal bypass surgery in patients with chronic limb-threatening ischemia.
    Bodewes TCF; Pothof AB; Darling JD; Deery SE; Jones DW; Soden PA; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 Dec; 66(6):1775-1785.e2. PubMed ID: 28822661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with delays in revascularization in patients with chronic limb-threatening ischaemia: population-based cohort study.
    Birmpili P; Johal A; Li Q; Waton S; Chetter I; Boyle JR; Cromwell D
    Br J Surg; 2021 Aug; 108(8):951-959. PubMed ID: 33842943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention.
    Jaramillo EA; Smith EJT; Matthay ZA; Sanders KM; Hiramoto JS; Gasper WJ; Conte MS; Iannuzzi JC
    J Vasc Surg; 2023 Mar; 77(3):848-857.e2. PubMed ID: 36334848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Sarcopenia With Mortality in Patients With Chronic Limb-Threatening Ischemia Undergoing Endovascular Revascularization.
    Cao Z; Zhao B; Jiang T; Zhang T; Yu X; Li Y; Wu W
    J Surg Res; 2023 Sep; 289():52-60. PubMed ID: 37084676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases.
    De Carlo M; Schlager O; Mazzolai L; Brodmann M; Espinola-Klein C; Staub D; Aboyans V; Sillesen H; Debus S; Venermo M; Belch J; Ferrari M; De Caterina R
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):201-207. PubMed ID: 36208909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
    Hess CN; Patel MR; Bauersachs RM; Anand SS; Debus ES; Nehler MR; Fanelli F; Yeh RW; Secemsky EA; Beckman JA; Mauri L; Govsyeyev N; Capell WH; Brackin T; Berkowitz SD; Muehlhofer E; Haskell LP; Hiatt WR; Bonaca MP
    J Am Coll Cardiol; 2021 Nov; 78(18):1768-1778. PubMed ID: 34711335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-Dependent Outcome of First-Line Endovascular and Surgical Revascularization Strategies in Chronic Limb-Threatening Ischemia.
    Smet N; Fourneau I; Roeleveld H; Boonman-de Winter L; Schraepen C; Favoreel M; van der Laan L
    Ann Vasc Surg; 2022 Sep; 85():133-145. PubMed ID: 35395378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factor Analysis and Long-Term Outcomes in Patients with Endovascular Revascularization for Intermittent Claudication or Chronic Limb-Threatening Ischemia.
    Fung V; Chan YC; Cheung GC; Cheng SW
    Ann Vasc Surg; 2023 Feb; 89():261-268. PubMed ID: 36162626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endovascular Therapy in an "All-Comers" Risk Group for Chronic Limb-Threatening Ischemia Demonstrates Safety and Efficacy When Compared with the Established Performance Criteria Proposed by the Society for Vascular Surgery.
    Montero-Baker M; Zulbaran-Rojas A; Chung J; Barshes NR; Elizondo-Adamchik H; Shahbazi M; Ross J; Rahemi H; Najafi B; Mills JL
    Ann Vasc Surg; 2020 Aug; 67():425-436. PubMed ID: 32209405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk prediction model for early outcomes of revascularization for chronic limb-threatening ischaemia.
    Miyata T; Mii S; Kumamaru H; Takahashi A; Miyata H;
    Br J Surg; 2021 Aug; 108(8):941-950. PubMed ID: 33693591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the Timing of Foot Tissue Resection on Outcomes in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia.
    Shannon AH; de Grijs DP; Goudreau BJ; Mehaffey JH; Cullen JM; Williams C; Robinson WP
    Angiology; 2021 Feb; 72(2):159-165. PubMed ID: 32945173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss.
    Brahmandam A; Gholitabar N; Cardella J; Nassiri N; Dardik A; Georgi M; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Jan; 70():237-244. PubMed ID: 32659417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes of chronic limb-threatening ischemia due to inflammatory nonatherosclerotic versus atherosclerotic etiologies undergoing revascularization.
    Iida O; Takahara M; Kodama A; Yamaoka T; Soga Y; Mano T
    Vasc Med; 2023 Aug; 28(4):299-307. PubMed ID: 37093717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
    Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
    J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease.
    Heffron SP; Ruuth MK; Xia Y; Hernandez G; Äikäs L; Rodriguez C; Öörni K; Berger JS
    Atherosclerosis; 2021 Jan; 316():53-57. PubMed ID: 33307457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP; Schanzer A; Flahive JM; Osborne NH; Mills JL; Bradbury AW; Conte MS
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S120-S134.e3. PubMed ID: 31151867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial.
    Baumgartner I; Norgren L; Fowkes FGR; Mulder H; Patel MR; Berger JS; Jones WS; Rockhold FW; Katona BG; Mahaffey K; Hiatt WR;
    J Am Coll Cardiol; 2018 Oct; 72(14):1563-1572. PubMed ID: 30261955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.